Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Former China Unicom Executive Gets 12 Years for Taking $3.8 Million in Bribes
GPT Weekly: OpenAI Completes Restructuring
Tech Brief (Oct. 31): China Launches $7.2 Billion Fund for Strategic Industries
LATEST
Tech Brief (Oct. 31): China Launches $7.2 Billion Fund for Strategic Industries
GPT Weekly: OpenAI Completes Restructuring
Tech Brief (Oct. 30): Nvidia Becomes First Tech Firm to Top $5 Trillion Market Cap
Former China Unicom Executive Gets 12 Years for Taking $3.8 Million in Bribes
Tech Brief (Oct. 29): China Unveils Five-Year Plan to Foster Emerging, Future Industries
Huawei’s Bold AI Bet Aims to Fill Nvidia’s Void in China
China’s STAR Market Embraces Unprofitable Tech With $14.6 Billion ESWIN Debut
China Mobile Names China Unicom Chief as New Chairman
MiniMax Unveils M2 Model to Compete on Speed and Cost
Pony AI, WeRide Seek to Raise Combined $1.3 Billion in Hong Kong
Tech Brief (Oct. 28): Meituan Releases Open-Source Video Generation Model
Tech Brief (Oct. 27): Huawei EV Partner Seres Unveils Hong Kong IPO Plan
Tech Brief (Oct. 24): China Vows to Accelerate Tech Self-Reliance
Tech Brief (Oct. 23): China Cracks Down on Smart Devices Over Data Violations
Chinese Firms Urged to Fortify Online Brands as Cybersquatting Costs Mount
Tech Brief (Oct. 16): China’s Tech Minister Meets With Apple CEO
China Debuts Ultrafast Oscilloscope in Drive to Break Tech Barriers
Tech Brief (Oct. 15): Google to Invest $15 Billion in India for AI Hub
Tech Brief (Oct. 13): Wingtech Temporarily Loses Control of Dutch Chipmaker Nexperia
Tech Brief (Oct. 10): China’s AI Server Market Doubles

By Han Wei / Dec 29, 2018 02:40 AM / Business & Tech

Photo: VCG

Photo: VCG

An initial investigation of herbal medicines and health foods producer Quanjian Group Co. Ltd. found that the company committed violations by exaggerating the benefits of its products, the state broadcaster China Central Television reported Friday.

A formal investigation has been initiated against Quanjian by the Tianjin city market regulator on allegations of violating market competition law, said the report.

Tianjin-based Quanjian has been under public scrutiny since Dingxiangyuan, an online health news portal, published an article Tuesday reporting that the company exaggerated the benefits of its products, which contributed to the 2015 death of a 4-year-old with cancer. Tianjin authorities sent inspectors to the company after the report went viral.

Quanjian also faces questions on whether it was involved in pyramid sales, which are banned in China. An official on the inspection team said the probe is still underway, according to the CCTV report.

Related: ‘Miracle’ Herbal Cures Accused of Contributing to Child's Death

Share this article
Open WeChat and scan the QR code